Trial intelligence / Profile preview

Luliconazole in Tinea Pedis, Tinea Corporis, or Tinea Cruris

NCT01349998Phase 3Completed

Sponsor
Tinea Pharmaceuticals, Inc.
Start
May 2011
Primary completion
Sep 2012
Countries
5
01

Overview

A Phase 3 trial of luliconazole in tinea pedis, Tinea cruris (TC), tinea corporis, sponsored by Tinea Pharmaceuticals, Inc.. Started May 2011; status: completed.

02

Drugs

luliconazole
03

Conditions

tinea pedisTinea cruris (TC)tinea corporis

Beyond the preview

Go deeper on NCT01349998.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01349998.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call